Chronic Weight Management clinical trials

Explore recruiting chronic weight management clinical trials.

Recruiting chronic weight management studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Weight Management trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-2)

Hungary, Italy, Czechia, Germany, Bulgaria, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-1)

Italy, Poland, Germany, Finland, Belgium, Denmark +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

C6501003 - A Phase 1, Open-Label, Randomized, Single Dose, Parallel Group Study to Assess Relative Bioavailability of PF-08653945 When Administered Across Different Injection Sites in Adults With Overweight or Obesity

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

J4M-MC-PWMP: A Master Protocol for a Randomized, Controlled, Clinical Platform Trial to Investigate the Efficacy and Safety of Interventions for Chronic Weight Management in Pediatric Participants with Obesity or Overweight (ADVANCE) J4M-MC-PW01: Efficacy, Safety, and Pharmacokinetics of Orforglipron Once Daily Oral versus Placebo in Adolescent Participants Who Have Obesity, or Overweight with Weight-Related Comorbidities: A Randomized, Double-Blind Trial (ADVANCE-ATTAIN-ADOLESCENTS)

Poland, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Weight Management trials by city

Chronic Weight Management in Toronto Chronic Weight Management in Vancouver Chronic Weight Management in Montreal Chronic Weight Management in Calgary Chronic Weight Management in Edmonton Chronic Weight Management in Ottawa Chronic Weight Management in Winnipeg Chronic Weight Management in Quebec City Chronic Weight Management in Hamilton Chronic Weight Management in Kitchener Chronic Weight Management in London Chronic Weight Management in Halifax Chronic Weight Management in New York Chronic Weight Management in Los Angeles Chronic Weight Management in Chicago Chronic Weight Management in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease